New Light on the New OSTP Memo: An Interview with Dr. Alondra Nelson
Karin Wulf and Rick Anderson interview Dr. Alondra Nelson, acting director of the White House Office on Science & Technology Policy when the new OSTP memo was published.
The New OSTP Memo: A Roundup of Reactions and an Interview Preview
Karin Wulf and Rick Anderson provide a roundup of responses to the new OSTP public access memo — and a preview of their interview with OSTP leadership.
A New OSTP Memo: Some Initial Observations and Questions
Some initial thoughts on the new OSTP memo on public access to results of federally funded research — and questions about its intent and implications.
10 Years of Public Access to the Results of Federally Funded Research: An Interview with the Scholarly Publishing Roundtable (Part 2)
An interview with principals of the Scholarly Publishing Roundtable, whose work significantly shaped the Holdren Memo on public access to federally-funded research.
10 Years of Public Access to the Results of Federally Funded Research: An Interview with the Scholarly Publishing Roundtable (Part 1)
An interview with principals of the Scholarly Publishing Roundtable, whose work significantly shaped the Holdren Memo on public access to federally-funded research.
Open Access, Academic Freedom, and the Spectrum of Coercive Power
Who has the most power to take choice away from authors?
PubMed Central Boosts Citations, Study Claims
Researchers claim that PMC boosts citations by 26%. A closer look at the paper reveals serious data and analysis problems. Can we collectively design a better study?
PubMed Central Reduces Publisher Traffic, Study Shows
PubMed Central reduces article downloads from 14 biomedical society websites when articles are made freely available after embargo.
Is PubMed Central Complementing or Competing with Journal Publishers?
Articles deposited into PubMed Central responsible for drawing readers from journal site, a study finds.
Open Access Embargoes — How Long Is Long Enough?
Most publishers offering delayed free access to journal articles set their embargo period more than a decade ago. Is it time to revisit the access embargo?
The Federal Research Public Access Act (FRPAA), Science, and the Public Good
If consumer web sites remain the source of most health information, there is little that FRPAA will do to improve the transmission of research to the public.
Dark Secrets: Open Access and Author Processing Charges
Transparency and accountability are at the heart of Open Access. If only library advocates would walk the talk.
Competing Views of Intellectual “Property”
The NIH Public Access Policy debate can be better understood through the lenses of competing Intellectual Property theories.